View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
FOLFIRI (Irinotecan 180 / Folinic Acid 400 / Fluorouracil 2400) / Panitumumab 6, Colorectal Carcinoma
Protocol-ID: 440 V1.2 (Mini), FOLFIRI (IRIN180/CFOL400/FU2400)/PNTM6, colorect. CaIndication(s)
- Colon Cancer (KRAS/NRAS WT); ICD-10 C18.0, C18.2, C18.3, C18.4, C18.5, C18.6, C18.7, C18.8, C19
Links
- Takayuki Yoshino Panitumumab (PAN) plus mFOLFOX6 versus bevacizumab (BEV) plus mFOLFOX6 as first-line treatment in patients with RAS wild-type (WT) metastatic colorectal cancer (mCRC): Results from the phase 3 PARADIGM trial. [ASCO Abstracts doi]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 19.12.2023